Bladder Leiomyoma in Men: Report of Two Cases and Review of the Literatüre
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 4
Abstract
Leiomyomas, which originate from smooth muscle cells, are considered as a benign mesenchymal neoplasm and rarely seen in the bladder. The clinical presentation of bladder leiomyoma might vary according to the size and location of the lesion. Recently, an optimal treatment option for bladder leiomyoma is still contradictive. Although surgical resection is the treatment of choice for all types of leiomyomas, some authors claim that asymptomatic and non-obstructive leiomyoma might be followed up since no malignant transformation of bladder leiomyoma has been reported. The treatment mainly consists of endoscopic resection; however, partial cystectomy may be required in some cases. We presented two male cases that had been followed up with the diagnosis of bladder leimyoma in accordance with the literature review.
Authors and Affiliations
Özgür Çakmak, Sevgi Vermişli, Okan Nabi Yalbuzdağ, Dudu Solakoğlu Kahraman, Samir Abdullazade
Importance of the Re-Transurethral Resection in Bladder Cancer Treatment
Objective: In this study, we aimed to investigate the importance of repeat-transurethral resection (re-TUR) in bladder cancer treatment. Materials and Methods: A total of 90 with the diagnosis of grade pTa and all pT1 bl...
Rare Benign and Uncertain Malignant Potential Tumors of Bladder: Review of the Literature
The most common primary bladder cancer are transitional cell (urothelial) carcinomas. However, there are several uncommon but significant bladder lesions that must be differentiated from urothelial carcinomas. These blad...
Squamous Metaplasia and Its Management in Non-malignant Bladder Diseases
Objective: To reveal possible associations between non-malignant bladder disease and malignancy by evaluating the pathologic examination results of patients who underwent cystectomy for non-malignant diseases and to sugg...
Evaluation of the Side Effect Profile of Intracavitary Bacillus Calmette-Guérin Treatment in Non-muscle-invasive Bladder Cancer
Objective: To reveal the association of side effect profiles seen in patients receiving intravesical bacillus Calmette-Guérin (BCG) immunotherapy for non-muscle-invasive bladder cancer (NMIBC) treatment with patient age...
Risk Factors for Urothelial Cancers
Urothelial cancers affect renal pelvis and ureters in the upper urinary tract, however they affect bladder and urethra in the lower urinary tract. The rate of the urothelial carcinoma makes up 3% pf cancers in the world....